Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Tags:
Grouped Articles
Big Pharma Faces Grim Prognosis
Wall Street Journal 12/06/2007
Wall Street Journal 06/27/2008
Europe Accuses Drug Makers of Padding Health Care Costs
New York Times 11/29/2008
EU Opens an Antitrust Probe Of Servier, Generic Drug Makers
Wall Street Journal 07/09/2009
Drug Firms Feel Pinch From Europe
Wall Street Journal 07/29/2010
Austerity in Europe Puts Pressure on Drug Companies
New York Times 02/23/2012
Grouped Articles
Drug Makers Finance Nurses for U.K. Doctors
Wall Street Journal 05/30/2007
Wall Street Journal 06/27/2008
Europe Accuses Drug Makers of Padding Health Care Costs
New York Times 11/29/2008
EU Blasts Drug Titans' Tactics
Wall Street Journal 11/29/2008
EU Opens an Antitrust Probe Of Servier, Generic Drug Makers
Wall Street Journal 07/09/2009
Europe Drug Makers Seek Deal on Crisis Pricing
Wall Street Journal 06/25/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1